First- and second-generation antipsychotics: Learning from CUtLASS and CATIE [1]

Archives of General Psychiatry

Volumn 64, Issue 8, 2007, Pages 977-978

  Tandon, Rajiv ^a   Carpenter, William T ^b   Davis, John M ^b  

^a UNIVERSITY OF FLORIDA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; PERPHENAZINE; QUETIAPINE; RISPERIDONE; ZIPRASIDONE;

BRADYPHRENIA; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; DYSPHORIA; EXTRAPYRAMIDAL SYNDROME; HUMAN; INTERVENTION STUDY; LEARNING; LETTER; NEGATIVE SYNDROME; RISK FACTOR; SCHIZOPHRENIA; TREATMENT OUTCOME;

ANTIPSYCHOTIC AGENTS; BASAL GANGLIA DISEASES; CLOZAPINE; HUMANS; MOOD DISORDERS; NEUROLEPTIC MALIGNANT SYNDROME; RANDOMIZED CONTROLLED TRIALS; SCHIZOPHRENIA; TREATMENT OUTCOME;

EID: 34547786159     PISSN: 0003990X     EISSN: 15383636     Source Type: Journal    
DOI: 10.1001/archpsyc.64.8.977     Document Type: Letter

References (9)

1. Jones PB, Barnes TR, Davies L, Dunn G, Lloyd H, Hayhurst KP, Murray RM, Markwick A, Lewis SW. Randomized controlled trial of effect on quality of life of second-generation versus first-generation antipsychotic drugs in schizophrenia. Arch Gen Psychiatry. 2006;63(10):1079-1087.
2. Lieberman JA. Comparative effectiveness of antipsychotic drugs: a commentary on Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1) and Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE). Arch Gen Psychiatry. 2006;63(10):1069-1072.
3. Lieberman JA, Stroup ST, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, Keefe RS, Davis SM, Davis CE, Lebowitz BD, Severe J, Hsiao JK; Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med. 2005;353(12):1209-1223.
4. Moran M. Experts square off across antipsychotic generation gap. Psychiatr News. 2005;40(13):1-3.
5. Tandon R. Comparative effectiveness of antipsychotics in the treatment of schizophrenia: what does CATIE tell us? - part 1. Int Drug Ther Newsl. 2006;41(7):51-58.
6. Tandon R. Comparative effectiveness of antipsychotics in the treatment of schizophrenia: what does CATIE tell us? - part 2. Int Drug Ther Newsl. 2006;41(9):67-74.
7. Davis JM, Marder SR, Tamminga CA. Switch or stay. Am J Psychiatry. 2006;163(12):2032-2033.
8. Essock SM, Covell NH, Davis SM, Stroup ST, Rosenheck RA, Lieberman JA. Effectiveness of switching antipsychotic medications. Am J Psychiatry. 2006;163(12):2090-2095.
9. Tandon R, Targum SD, Nasrallah HA, Ross R. Strategies for maximizing clinical effectiveness in the treatment of schizophrenia. J Psychiatr Pract. 2006;12(6):348-363.